| The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review A Nabizadeh, B Amani, M Kadivar, M Toroski, AA Asl, Y Bayazidi, ... Journal of Research in Pharmacy Practice 7 (4), 171-177, 2018 | 14 | 2018 |
| Gender gap and inequality in health professionals’ income in Iran EH Rad, Y Bayazidi, S Delavari, S Rezaei Medical Journal of Bakırköy 12 (2), 74-79, 2016 | 12 | 2016 |
| Comparing the socioeconomic determinants of infant mortality rate in Iran and MENA countries RADE HOMAIE, ALIH SAMADI, Y BAYAZIDI, R HAYATI Journal of Economic Modeling Research 3 (12), 135-151, 2013 | 11 | 2013 |
| The prescription pattern of antidiabetic medication and glycemic control in type 2 diabetes in Iran: a patient level study M Davari, Y Bayazidi, A Esteghamati, B Larijani, A Kebriaeezadeh Diabetes Manag 9 (2), 57-65, 2019 | 8 | 2019 |
| The impact of research and development and marketing costs on the profitability of pharmaceutical companies of Tehran Stock Exchange using panel data 2001-2013 Y Bayazidi, E Homaie Rad, M Mojahedian, M Toroski, A Nabizadeh, ... International Journal of Pharmaceutical and Healthcare Marketing 10 (4), 467-476, 2016 | 7 | 2016 |
| Examine socio-economic factors affecting infant mortality rate in MENA countries E Homaee Rad, A Samadi, Y Bayazidi, R Hayati Economic Modeling Research 2 (5), 135-151, 2013 | 7 | 2013 |
| Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data M Davari, Y Bayazidi, A Kebriaeezadeh, A Esteghamati, F Bandarian, ... BMC Endocrine Disorders 22 (1), 133, 2022 | 5 | 2022 |
| Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran R Daroudi, O Shafe, J Moosavi, J Salimi, Y Bayazidi, MR Zafarghandi, ... Cost Effectiveness and Resource Allocation 19 (1), 29, 2021 | 2 | 2021 |
| Homaie Rad E, Varmaghani M, Kokabisaghi F. Inequity in Access of Statins in Iran: A Panel Study Using Provincial Data R Tabari-Khomeiran, Y Bayazidi, S Nikfar Caspian J Health Res 4 (2), 33-7, 2019 | 2 | 2019 |
| Cost-Utility Analysis of Single-Fraction Versus Multiple-Fraction Radiotherapy in Patients with Painful Bone Metastases: An Iranian Patient’s Perspective Study Y Bayazidi, A Keshtkaran, EH Rad, M Ansari, M Javanbakht, AH Meshkini, ... Value in health regional issues 12, 84-89, 2017 | 2 | 2017 |
| Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis A Sadeghi, Y Bayazidi, M Davari, A Kebriaeezadeh, A Assarian, ... Iranian Journal of Medical Sciences 48 (3), 286, 2023 | 1 | 2023 |
| Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran RS Shahtaheri, Y Bayazidi, M Davari, A Kebriaeezadeh, S Yousefi, ... Health Economics Review 12 (1), 44, 2022 | 1 | 2022 |
| The Estimation of the Imposed Economic Burden Due to Inadequate Medical Care in Patients Suffering from Type 2 Diabetes in Tehran Y Bayazidi, M Davari Social Security Journal 15 (4), 121-131, 2020 | 1 | 2020 |
| İran sağlık çalışanlarında cinsiyet farkı ve eşitsizliği EH Rad, Y Bayazidi, S Delavari, S Rezaei Bakırköy Tıp Dergisi 12 (2), 70-75, 2016 | | 2016 |
| Comparison of quality of life in patients with bone metastasis under treatment with single fraction and multiple fraction radiotherapy methods in Shiraz during 2012 Y Bayazidi, E Homaie Rad Razi Journal of Medical Sciences 21 (128), 28-36, 2015 | | 2015 |
Enayatollah Homaie RadSocial Determinants of Health Research Center, Trauma Institute, Guilan University of MedicalVerified email at gums.ac.ir
